₹27.39
▼ -0.54 -1.93%
17 Jul 2026
NSE Listed
Mangalam Drug & Chem Ltd. (MANGALAM)
Volume: 14,725Avg Vol 1W: 29,285.2Avg Vol 1M: 40,600.352W Range:₹22.8₹95
Key Ratios
Checked 20h agoMarket Cap₹44 Cr
Current Price₹27.39
Previous Close₹27.93
High / Low (52w)₹95 / ₹22.8
Volume14,725
Avg Vol (1W)29,285.2
Avg Vol (1M)40,600.3
Stock P/E17.46
Book Value₹65.1
Dividend Yield0%
ROE-43.1%
ROA-14.1%
Revenue (TTM)₹319 Cr
Revenue Growth-13.7%
Profit Margin-19.1%
Total Debt₹9 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹-8.48
P/B0.43
Debt / Equity1.02
50 DMA₹28.82
200 DMA₹37.01
Day change-1.93%
Price Chart
₹27.39▼ 68.21% · 1Y
2025-07-162026-07-15
20-day avg volume: 41K shares
Pros
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 26% YoY.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹77 Cr | ₹80 Cr | ₹89 Cr | ₹73 Cr | ₹57 Cr | ₹50 Cr | ₹58 Cr | ₹67 Cr |
| EBITDA | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹-9 Cr | ₹-7 Cr | ₹-6 Cr | ₹-10 Cr |
| Net Profit | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹0 Cr | ₹-14 Cr | ₹-7 Cr | ₹-10 Cr | ₹-13 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | ₹284 Cr | ₹385 Cr | ₹451 Cr | ₹373 Cr | ₹369 Cr | ₹319 Cr |
| EBITDA | ₹17 Cr | ₹49 Cr | ₹39 Cr | ₹15 Cr | ₹3 Cr | ₹20 Cr |
| Net Profit | ₹8 Cr | ₹28 Cr | ₹20 Cr | ₹1 Cr | ₹-9 Cr | ₹7 Cr |
| EPS | 5.21 | 17.67 | 12.42 | 0.8 | -5.73 | 4.25 |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Total Assets | ₹231 Cr | ₹264 Cr | ₹328 Cr | ₹358 Cr | ₹334 Cr | ₹366 Cr |
| Total Liabilities | ₹127 Cr | ₹133 Cr | ₹178 Cr | ₹206 Cr | ₹198 Cr | ₹217 Cr |
| Equity | ₹104 Cr | ₹131 Cr | ₹151 Cr | ₹152 Cr | ₹136 Cr | ₹149 Cr |
| Total Debt | ₹4 Cr | ₹7 Cr | ₹25 Cr | ₹19 Cr | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹37 Cr | ₹35 Cr | ₹38 Cr | ₹4 Cr | ₹43 Cr |
| Investing | ₹-31 Cr | ₹-27 Cr | ₹-22 Cr | ₹-12 Cr | ₹-19 Cr |
| Financing | ₹3 Cr | ₹3 Cr | ₹-17 Cr | ₹5 Cr | ₹-22 Cr |
| Free Cash Flow | ₹37 Cr | ₹35 Cr | ₹38 Cr | ₹4 Cr | ₹43 Cr |
Shareholding
Promoter 35.65% Institutions 0.11% Public 64.24%
Efficiency & Working Capital
ROCE-15.4%
Interest Coverage1.3
Dividend Payout—
Debtor Days45 d
Inventory Days159 d
Payable Days105 d
Cash Conversion Cycle99 d
Working Capital Days204 d
Shareholding Details
As of 2026-06-30
Promoter35.7%
FII0.1%
DII0%
Institutions0.1%
Public64.2%
Promoter Pledge0%
No. of Shareholders24,465
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 50.3% | 50.3% | 50.3% | 50.3% | 50.3% | 50.3% | 50.3% | 50.3% | 50.3% | 35.6% | 35.7% | 35.7% |
| FIIs | 0.1% | 0.1% | 0.3% | 0.2% | 0.1% | 0.1% | 0.5% | 0.5% | 0.1% | 0.1% | 0.3% | 0.1% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 49.6% | 49.6% | 49.4% | 49.5% | 49.6% | 49.6% | 49.2% | 49.2% | 49.6% | 64.2% | 64% | 64.2% |
| Promoter Pledge | 17.5% | 18.1% | 17.6% | 14.9% | 10.3% | 11% | 13.2% | 13.2% | 34.6% | 7.1% | 0% | 0% |
| No. of Shareholders | 17,978 | 18,610 | 19,173 | 19,312 | 19,508 | 19,679 | 19,697 | 19,728 | 19,881 | 21,227 | 25,140 | 24,465 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Shree Rasbihari Trading & Investment Pvt Ltd | Shareholding of Promoter and Promoter Group | 6.2% | 9,82,563 |
| Shri Jb Pharma Private Limited | Shareholding of Promoter and Promoter Group | 6% | 9,50,000 |
| Dhoot Goverdhan Murlidhar | Shareholding of Promoter and Promoter Group | 3.2% | 5,11,792 |
| Shree Kishoriju Trading & Investment Pvt Ltd | Shareholding of Promoter and Promoter Group | 3.2% | 5,08,599 |
| Brijmohan Murlidhar Dhoot | Shareholding of Promoter and Promoter Group | 3.1% | 4,86,996 |
| Shweta Goverdhan Dhoot | Shareholding of Promoter and Promoter Group | 2.6% | 4,10,000 |
| Radhika Ajay Dhoot | Shareholding of Promoter and Promoter Group | 1.9% | 2,92,500 |
| Smita Aditya Dhoot | Shareholding of Promoter and Promoter Group | 1.9% | 2,92,500 |
| Rajkumari R. Dhoot | Shareholding of Promoter and Promoter Group | 1.7% | 2,75,948 |
| Raj Exports Pvt Ltd | Shareholding of Promoter and Promoter Group | 1.2% | 1,91,520 |
| Thakkalapalli Sampath Rao | Public Shareholding | 1% | 1,63,087 |
| Anish Dwivedi | Public Shareholding | 1% | 1,59,998 |
| Govardhan Murlidhar Dhoot | Shareholding of Promoter and Promoter Group | 1% | 1,55,330 |
| Rekha Goverdhan Dhoot | Shareholding of Promoter and Promoter Group | 0.9% | 1,46,760 |
| Ajay Ramniwas Dhoot | Shareholding of Promoter and Promoter Group | 0.9% | 1,38,687 |
| Jyoti Brijmohan Dhoot | Shareholding of Promoter and Promoter Group | 0.7% | 1,04,550 |
| Aditya R Dhoot | Shareholding of Promoter and Promoter Group | 0.6% | 89,225 |
| Brijmohan Murlidhar Dhoot | Shareholding of Promoter and Promoter Group | 0.5% | 77,473 |
| Rajkamal Sukhani | Shareholding of Promoter and Promoter Group | 0.2% | 28,520 |
| Chandrakanta Murlidhar Dhoot | Shareholding of Promoter and Promoter Group | 0% | 67 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Dhoot Goverdhan Murlidhar | 0 | 0% | 2026-06-30 |
| Brijmohan Murlidhar Dhoot | 0 | 0% | 2026-06-30 |
| Shweta Goverdhan Dhoot | 0 | 0% | 2026-06-30 |
| Radhika Ajay Dhoot | 0 | 0% | 2026-06-30 |
| Smita Aditya Dhoot | 0 | 0% | 2026-06-30 |
| Rajkumari R. Dhoot | 0 | 0% | 2026-06-30 |
| Govardhan Murlidhar Dhoot | 0 | 0% | 2026-06-30 |
| Rekha Goverdhan Dhoot | 0 | 0% | 2026-06-30 |
| Ajay Ramniwas Dhoot | 0 | 0% | 2026-06-30 |
| Jyoti Brijmohan Dhoot | 0 | 0% | 2026-06-30 |
| Aditya R Dhoot | 0 | 0% | 2026-06-30 |
| Brijmohan Murlidhar Dhoot | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Govardhan M Dhoot | Chairman / Executive Director / Managing Director | 2025 |
| Brijmohan Dhoot | E D & Wholetime Director | 2025 |
| Nidhi S. Mundada | Independent Non Exe. Director | 2025 |
| Praveen Saxena | Independent Non Exe. Director | 2025 |
| Rakesh K. Milwani | Non-Exec & Non-Independent Dir | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Bulk Drugs | ₹108 Cr | 96.1% |
| Chemicals & Others | ₹4 Cr | 3.9% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Domestic | ₹185 Cr | 81.4% |
| Export | ₹42 Cr | 18.6% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 30 | 16 | 16 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 24 | 0 | 0 | 1 | 5 | 31 |
| 2025 | 24 | 0 | 0 | 0 | 0 | 24 |
| 2025 | 0 | 0 | 0 | 1 | 1 | 4 |
Insider / Designated-Person Trades
30 recent disclosure(s)
SHREE KISHORIJU TRADING AND INVESTMENT PRIVATE LIMITEDRevoke · 1,500
AJAY RAMNIWAS DHOOTRevoke · 1,38,000
ADITYA RAMNIWAS DHOOTRevoke · 89,000
SHREE RASBIHARI TRADING AND INVESTMENTS PRIVATE LIMITEDRevoke · 1,73,000
SHREE KISHORIJU TRADING AND INVESTMENT PRIVATE LIMITEDRevoke · 1,37,484
SHRI JB PHARMA PRIVATE LIMITEDInvoke · 17,00,000
Substantial Acquisitions (SAST)
1 disclosure(s)
Market30/03/2022 · 20,000
Company Information
🌐 www.mangalamdrugs.com ↗
📍 3rd Floor Rupam Building, 239 P D Mello Road, Mumbai, Maharashtra, 400001
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search